Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Patient Compliance × Specimen Handling × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 56 Triple Negative Breast Neoplasms 28 Lung Neoplasms 12 Prostatic Neoplasms 10 Neoplasm Metastasis 10 Carcinoma, Intraductal, Noninfiltrating 10 Anatomic Stage I Breast Cancer AJCC v8 9 Carcinoma, Non-Small-Cell Lung 8 Breast Carcinoma In Situ 8 Ovarian Neoplasms 6 Melanoma 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Meningeal Carcinomatosis 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Multiple Myeloma 4 Colonic Neoplasms 4 Brain Neoplasms 4 Small Cell Lung Carcinoma 3 Inflammatory Breast Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Anatomic Stage IV Breast Cancer AJCC v8 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Obesity 2

Interventions

Anastrozole 2 beta-Aminoethyl Isothiourea 1 Trastuzumab 1 Surveys and Questionnaires 1 Specimen Handling 1 Nutrition Assessment 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Motivational Interviewing 1 Leuprolide 1 Lapatinib 1 Interviews as Topic 1 Goserelin 1 Exercise 1 Diet Therapy 1 Clodronic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06635005 2025-10-16

LIN-BRiCK

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡